adenosine has been researched along with Skin Neoplasms in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (53.33) | 24.3611 |
| 2020's | 10 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bagot, M; Bensussan, A; Bozonnat, A; de Masson, A; Dumont, M; Marie-Cardine, A; Ram-Wolff, C; Sonigo, G; Thonnart, N | 1 |
| Bracci, C; Fia, M; Funaro, A; Marchisio, S; Ortolan, E; Quaglino, P; Ribero, S; Rumore, MR; Senetta, R; Tampieri, C; Yakymiv, Y | 1 |
| Liang, P; Yan, Z | 1 |
| Jiang, B; Liang, P; Ran, Y; Yan, Z | 1 |
| Jones, CL; Whittaker, S | 1 |
| Chen, H; Cheng, J; Du, J; Fu, J; He, T; Zhang, L; Zhang, W | 1 |
| Cao, S; Liu, C; Wang, X; Yang, S | 1 |
| André, F; Bastide, A; David, A; Desaubry, L; Eggermont, A; Faouzi, S; Fu, Y; Malka-Mahieu, H; Martineau, S; Mateus, C; Robert, C; Routier, E; Roy, S; Scoazec, JY; Shen, S; Sun, X; Vagner, S | 1 |
| Li, F; Lin, Y; Liu, S; Lv, S; Wang, H; Wang, S | 1 |
| Cook, JL; Corcoran, DL; Degan, S; Erdmann, D; Havran, WL; Healy, E; Jiang, SW; Lai, C; Levinson, H; MacLeod, AS; Reid, C; Robson, SC; Rudolph, R; Spasojevic, I; Suwanpradid, J; Whitley, MJ; Zelac, DE; Zhang, JY | 1 |
| Han, P; Liao, Y; Ni, B; Zhang, Y | 1 |
| Ahern, E; Bald, T; Barkauskas, DS; Boyle, GM; Chitsazan, A; Hölzel, M; Huntington, ND; Landsberg, J; Long, GV; Madore, J; Ngiow, SF; Rautela, J; Reinhardt, J; Schadendorf, D; Scolyer, RA; Smyth, MJ; Young, A | 1 |
| Borgognoni, L; Brandani, P; Caporale, R; Di Gennaro, P; Gerlini, G; Pimpinelli, N; Sestini, S; Urso, C | 1 |
| Bar-Eli, M; Brooks, D; Calin, G; Fuentes-Mattei, E; Huang, L; Ivan, C; Jones, SJM; Kim, SJ; Lopez-Berenstein, G; Paret, H; Robertson, AG; Rodriguez-Aguayo, C; Shoshan, E; Sood, A; Velazquez-Torres, G; Xie, V | 1 |
| Gao, Y; Li, Q; Lv, D; Wang, C; Wang, D; Zhou, R | 1 |
| Donovan, NC; Hoon, DSB; Irie, RF; Tanaka, R; Yu, Q | 1 |
| Bazhin, AV; Shevchenko, I; Umansky, V; Utikal, J | 1 |
| Bar-Eli, M; Birol, I; Braeuer, RR; Brooks, D; Calin, GA; Eterovic, AK; Fidler, IJ; Gershenwald, JE; Huang, L; Hwu, P; Ivan, C; Jones, SJ; Kamiya, T; Kim, SJ; Lee, HJ; Markel, G; Mobley, AK; Mosqueda, M; Nip, KM; Robertson, AG; Salameh, A; Shoshan, E; Sood, AK; Vasquez, ME; Velazquez-Torres, G; Wen, YY; Zhu, K | 1 |
| Ackroyd, J; Bagati, A; Berman, AE; Bianchi-Smiraglia, A; Bshara, W; Fink, EE; Foley, CE; Marvin, EK; Moparthy, S; Morozevich, GE; Nikiforov, MA; Shewach, DS; Wawrzyniak, JA | 1 |
| Bosserhoff, AK; Dietrich, P | 1 |
| Carrega, P; Chillemi, A; Ferlazzo, G; Horenstein, AL; Malavasi, F; Mingari, MC; Morandi, B; Morandi, F; Moretta, L; Pistoia, V; Quarona, V; Zaccarello, G | 1 |
| Andreu-Pérez, P; Avila, MA; Cortés, J; Gil, R; Grueso, J; Hernandez-Losa, J; Moliné, T; Pujol, A; Recio, JA | 1 |
| Gorelik, E; Jackson, EK; Su, Y | 1 |
| Adcock, IM; Arra, C; Luciano, A; Maiolino, P; Montinaro, A; Morello, S; Ngkelo, A; Pinto, A; Sorrentino, R | 1 |
| Balasubramanian, S; Chew, YC; Choudhury, SR; Eckert, RL; Han, B; Marquez, VE | 1 |
| Korenstein, R; Madi, L; Nyska, A; Rosenberg-Haggen, B | 1 |
| Dante, R; Niveleau, A | 1 |
| Bloch, A; Burgess, GH; Holtermann, OA; Klein, E; Milgrom, H | 1 |
| Nozue, AT; Ono, S | 1 |
| Bloch, A; Burgess, GH; Helm, F; Klein, E; Milgrom, H; Stoll, H | 1 |
4 review(s) available for adenosine and Skin Neoplasms
| Article | Year |
|---|---|
N6-methyladenosine functions and its role in skin cancer.
Topics: Adenosine; Animals; Humans; Mammals; Methylation; Skin Neoplasms | 2023 |
Research Progress of m
Topics: Adenosine; Carcinoma, Squamous Cell; Humans; Methylation; Methyltransferases; RNA; Skin Diseases; Skin Neoplasms | 2023 |
Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Topics: Adenosine; Gene Expression; Humans; Melanoma; Methylation; Methyltransferases; Mutation; Oxidoreductases, N-Demethylating; Proto-Oncogene Proteins B-raf; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA, Messenger; Skin Neoplasms | 2021 |
Extracellular adenosine metabolism in immune cells in melanoma.
Topics: Adenosine; Animals; Cell Line, Tumor; Humans; Melanoma; Mice; Skin Neoplasms; T-Lymphocytes | 2014 |
26 other study(ies) available for adenosine and Skin Neoplasms
| Article | Year |
|---|---|
Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome.
Topics: 5'-Nucleotidase; Adenosine; Antibody-Dependent Cell Cytotoxicity; Antigens, CD; Apyrase; Cell Proliferation; Humans; Killer Cells, Natural; Sezary Syndrome; Skin Neoplasms | 2022 |
CD39/CD73 dysregulation and adenosine metabolism contribute to T-cell immunosuppression in patients with Sézary syndrome.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Apyrase; Humans; Immune Tolerance; Immunosuppression Therapy; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2023 |
m6A modification of mRNA in skin diseases.
Topics: Adenosine; Carcinoma, Squamous Cell; Humans; Quality of Life; RNA, Messenger; Skin Neoplasms | 2022 |
CD39-CD73-adenosine effects in Sézary syndrome.
Topics: Adenosine; Adenosine Triphosphate; Humans; Immunosuppression Therapy; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes | 2023 |
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m
Topics: Adenocarcinoma; Adenosine; Carcinoma, Hepatocellular; COVID-19; Dipeptidyl Peptidase 4; Female; Humans; Immunity; Liver Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Pancreatic Neoplasms; Pandemics; Prospective Studies; SARS-CoV-2; Skin Neoplasms | 2023 |
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells.
Topics: 5' Untranslated Regions; Adenosine; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Eukaryotic Initiation Factor-4A; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase Kinases; Melanoma; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; RNA Helicases; RNA, Messenger; Skin Neoplasms; Transcription, Genetic | 2019 |
Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
Topics: Adenosine; Disease Progression; DNA Copy Number Variations; Gene Expression Regulation, Neoplastic; Genomics; Humans; Melanoma; Polymorphism, Single Nucleotide; Skin Neoplasms; Transcriptome; Unsupervised Machine Learning | 2021 |
ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma.
Topics: Adenosine; Apyrase; Carcinoma, Squamous Cell; DNA Damage; DNA Repair; Forkhead Transcription Factors; Humans; Interleukin-27; Memory T Cells; Neoplasm Metastasis; Programmed Cell Death 1 Receptor; Skin Neoplasms; Ultraviolet Rays | 2021 |
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.
Topics: 5'-Nucleotidase; Adenosine; Animals; Drug Therapy, Combination; GPI-Linked Proteins; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Kinase 1; Melanoma; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Mutation; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Receptor, Adenosine A2A; Skin Neoplasms | 2017 |
T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Immune Tolerance; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Middle Aged; Neoplasm Staging; Sentinel Lymph Node; Skin Neoplasms; T-Lymphocytes, Regulatory | 2018 |
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
Topics: 3' Untranslated Regions; Adenosine; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; Melanoma; Mice; Mice, Nude; Microfilament Proteins; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogenes; RNA Editing; Skin Neoplasms | 2018 |
METTL3 mediated m
Topics: Adenosine; Animals; Carcinogenesis; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Cell Self Renewal; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heterografts; Humans; Methyltransferases; Mice; Mice, Nude; RNA Processing, Post-Transcriptional; RNA, Messenger; Skin Neoplasms; Transcription Factors; Tumor Suppressor Proteins | 2019 |
Tumor necrosis factor-α and apoptosis induction in melanoma cells through histone modification by 3-deazaneplanocin A.
Topics: Adenosine; Adenosylhomocysteinase; Apoptosis; Cell Line, Tumor; Histones; Humans; Melanoma; Skin Neoplasms; Tumor Necrosis Factor-alpha | 2014 |
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
Topics: Adenosine; Adenosine Deaminase; Animals; Base Sequence; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Inosine; Luciferases; Melanoma; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Neoplasm Metastasis; Neoplasm Transplantation; RNA Editing; RNA-Binding Proteins; Skin Neoplasms; Transcription Factors | 2015 |
Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity.
Topics: Adenosine; Animals; Cell Line, Tumor; Enzyme Inhibitors; Female; Guanosine Monophosphate; Humans; Immunoblotting; Immunohistochemistry; Melanoma; Melanoma, Cutaneous Malignant; Mice; Mice, SCID; Nucleotidyltransferases; Skin Neoplasms | 2015 |
Modifying microRNAs--another piece of the melanoma puzzle.
Topics: Adenosine; Animals; Female; Gene Expression Regulation, Neoplastic; Humans; Inosine; Melanocytes; Melanoma; MicroRNAs; RNA Editing; Skin Neoplasms | 2015 |
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation.
Topics: 5'-Nucleotidase; Adenosine; ADP-ribosyl Cyclase 1; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; GPI-Linked Proteins; Humans; Immunologic Memory; Kinetics; Lymphocyte Activation; Melanoma; Membrane Glycoproteins; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Signal Transduction; Skin Neoplasms | 2015 |
Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Genes, ras; Humans; Male; Melanoma; Mice; Mutation; Phosphorylation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6; Skin Neoplasms; Thionucleosides; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
Topics: Adenosine; Alprostadil; Cells, Cultured; Cytotoxicity, Immunologic; Dinoprostone; Humans; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Melanoma; Phenethylamines; Receptor Cross-Talk; Receptor, Adenosine A2A; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Skin Neoplasms; T-Lymphocyte Subsets | 2011 |
NK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.
Topics: Adenosine; Animals; Antimetabolites, Antineoplastic; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemotaxis, Leukocyte; Female; Immunity, Cellular; Killer Cells, Natural; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Skin Neoplasms; Tumor Microenvironment | 2011 |
(-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.
Topics: Acetylation; Adenosine; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Carrier Proteins; Caspases; Catechin; Cell Cycle; Cell Proliferation; Cells, Cultured; DNA Methylation; DNA-Binding Proteins; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Histone Deacetylase 1; Histones; Humans; Keratinocytes; Membrane Potential, Mitochondrial; Neoplasm Proteins; Nuclear Proteins; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Polycomb-Group Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Repressor Proteins; Skin Neoplasms; Transcription Factors; Ubiquitination | 2011 |
Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
Topics: Adenosine; Androstadienes; Cell Line, Tumor; Cyclic AMP; Dihydroxyphenylalanine; Humans; In Vitro Techniques; Keratinocytes; MAP Kinase Signaling System; Melanoma, Experimental; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Phosphatidylinositol 3-Kinases; Phosphorylation; Pigmentation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A3; Skin; Skin Neoplasms; Wortmannin | 2013 |
Inhibition of in vitro translation by antibodies directed against N6-methyladenosine.
Topics: Adenosine; Cells, Cultured; Humans; Immunoglobulin G; Protein Biosynthesis; RNA Caps; RNA, Messenger; Simplexvirus; Skin Neoplasms; Time Factors | 1981 |
The effects of nucleoside analogs on cutaneous neoplasms.
Topics: 3-Deazauridine; Adenosine; Carcinoma, Basal Cell; Humans; Male; Ribonucleosides; Skin Neoplasms; Sulfonamides; Tubercidin; Uridine | 1975 |
Exposure of newborn mice to adenosine causes neural crest dysplasia and tumor formation.
Topics: Adenosine; Adrenal Gland Neoplasms; Animals; Animals, Newborn; Bone Neoplasms; Carotid Body Tumor; Digestive System Neoplasms; Melanins; Melanoma; Mice; Mice, Inbred ICR; Muscular Diseases; Neoplasms, Experimental; Nervous System Neoplasms; Neural Crest; Neurofibroma; Peripheral Nervous System Neoplasms; Pheochromocytoma; Pigmentation Disorders; Skin Neoplasms; Tongue Neoplasms | 1989 |
Effect of topical tubercidin on basal cell carcinomas and actinic keratoses.
Topics: Adenosine; Administration, Topical; Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratosis; Male; Middle Aged; Skin Neoplasms | 1974 |